Last week, the National Institutes of Health (NIH), part of the U.S. Department of Health and Human Services, also known as the ‘nation’s medical research agency’, reported findings from a Virginia Commonwealth University School of Nursing clinical trial which showed that showed that the use of Calmare Pain Therapy Treatment (scrambler therapy) as a drug-free treatment to lessen or eliminate low back pain yielded impressive results:
- Thirty participants were randomized to receive up to 10 sessions of Calmare® treatment (n = 15) or a ‘sham’ treatment (n = 15) using the same device at a non-therapeutic threshold.
- 3 weeks after conclusion of treatment series, compared with the sham group, the Calmare® group reported a significant decrease in the “worst” pain and interference scores.
- There were also significant differences in pain sensitivity and differential expression of 17 pain genes, suggesting that Calmare® can be effective in reducing pain intensity and interference in individuals with persistent low back pain by altering the mechanisms of enhanced pain sensitivity.
This is outstanding news reported by an organization affiliated with the federal government. Might someone on the NIH team have become aware of Calmare’s effectiveness as a result of its expanded use in the largest U.S. Military hospitals across the globe?
Calmare Therapy can help lessen or eliminate several types of neuropathic pain with none of the unpleasant costs or side effects associated with painkillers (opioids).
Often, the out-of-pocket charges for Calmare Therapy are comparable to those patients must incur for their various medications for pain.
ClinicalTrials.gov processed this record on January 12, 2015.